Clinical Trial Update: S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating docetaxel plus carboplatin in metastatic or recurrent head and neck cancer, with the study (S9902…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED